$BPMC Blueprint Medicines Corp Insider Trading Week 12/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp in week 12/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 51.52 | 774 | 39,876 | 15,250 | 16 K to 15.3 K (-4.83 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 53.43 | 241 | 12,877 | 16,024 | 16.3 K to 16 K (-1.48 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 55.14 | 199 | 10,973 | 16,265 | 16.5 K to 16.3 K (-1.21 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 19,920 | 175,296 | 87,170 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 80 | 150 | 0 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 173,903 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 50.40 | 3,337 | 168,185 | 141,434 | 144.8 K to 141.4 K (-2.31 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.30 | 8,850 | 454,005 | 144,771 | 153.6 K to 144.8 K (-5.76 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 52.11 | 2,100 | 109,431 | 153,621 | 155.7 K to 153.6 K (-1.35 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 53.54 | 1,936 | 103,653 | 155,721 | 157.7 K to 155.7 K (-1.23 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 54.62 | 3,293 | 179,864 | 157,657 | 161 K to 157.7 K (-2.05 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 55.34 | 484 | 26,785 | 160,950 | 161.4 K to 161 K (-0.30 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 19,920 | 175,296 | 161,434 | 141.5 K to 161.4 K (+14.08 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 80 | 150 | 141,514 | 141.4 K to 141.5 K (+0.06 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 141,434 | 121.4 K to 141.4 K (+16.47 %) |